65 results
8-K
EX-99.1
IMCR
Immunocore Holdings plc
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
is expected to close on February 2, 2024, subject to the satisfaction of customary closing conditions. The offering was upsized from the previously … ) and the satisfaction of customary closing conditions related to the offering; and unanticipated uses of capital. For a further description of the risks
S-8
EX-99.6
IMCR
Immunocore Holdings plc
12 Apr 21
Registration of securities for employees
4:02pm
in accordance with the terms of his contract of employment; or
injury, ill-health or disability (evidenced to the satisfaction of the Directors … prior to the expiry of the six month period referred to above;
(ii)
an Option the exercise of which is subject to the satisfaction of a condition
F-3ASR
EX-4.4
IMCR
Immunocore Holdings plc
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
of Redemption
Section 3.03
Payment Upon Redemption
Section 3.04
Sinking Fund
Section 3.05
Satisfaction of Sinking Fund Payments with Securities
Section … Substituted
article 11
SATISFACTION AND DISCHARGE
Section 11.01
Satisfaction and Discharge of Indenture
Section 11.02
Discharge of Obligations
Section
F-1/A
EX-4.3
IMCR
Immunocore Holdings plc
1 Feb 21
Registration statement (foreign) (amended)
6:21am
to the satisfaction or waiver of the Conditions (other than those Conditions that are to be satisfied on the Closing) simultaneously with the closing … are subject to the satisfaction (or, if permitted by law, waiver in writing by the Subscriber), at or prior to the Closing Date, of the following
10-K
2023 FY
EX-10.12
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
such failure to the Board’s reasonable satisfaction in its sole discretion; (iii) Executive’s committing any act which constitutes a breach … to cure such failure to Board’s reasonable satisfaction in its sole discretion; (v) Executive’s material breach of any provision of this Agreement, any
F-1/A
EX-4.3
xm5pxo1h
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
DRS/A
EX-10.12
j606ay82pfn5
22 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
sqhbnkeh
22 Dec 20
Draft registration statement (amended)
12:00am
F-1
EX-10.15
p65qsy5nme id295tq
15 Jan 21
Registration statement (foreign)
4:57pm
F-1
EX-10.13
utce6ra76ou
15 Jan 21
Registration statement (foreign)
4:57pm
F-1/A
EX-10.18
3hoojww 38xwr46ltt
1 Feb 21
Registration statement (foreign) (amended)
6:21am
10-K
EX-10.13
6ur4y1eatx0l
28 Feb 24
Annual report
7:33am
F-1
EX-10.14
tp0u 3jxx6nz
15 Jan 21
Registration statement (foreign)
4:57pm
DRS/A
EX-10.13
lv2z6crjff
22 Dec 20
Draft registration statement (amended)
12:00am
8-K
EX-99.1
axjb9bzd
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
6-K
c1zbuh 7ysa1g
20 Jul 22
Securities Purchase Agreement
4:06pm
10-K
EX-10.14
qthcy3nxwz3das 8y6
28 Feb 24
Annual report
7:33am
S-8
EX-99.2
umacaq54tu785e rqkr
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.1
rhq2 6frpm6lwbr
12 Apr 21
Registration of securities for employees
4:02pm
8-K
EX-4.1
59eqi s5nixb
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm